|
TFB2M expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.71630504147902E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.99233987483194E-12 |
| Normal-vs-Stage2 |
1.89169999997851E-06 |
| Normal-vs-Stage3 |
6.940500E-03 |
| Normal-vs-Stage4 |
3.865600E-02 |
| Stage1-vs-Stage2 |
5.497200E-01 |
| Stage1-vs-Stage3 |
3.228300E-02 |
| Stage1-vs-Stage4 |
5.446300E-02 |
| Stage2-vs-Stage3 |
2.533800E-01 |
| Stage2-vs-Stage4 |
1.061650E-01 |
| Stage3-vs-Stage4 |
6.609000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.49609991062505E-10 |
| Normal-vs-AfricanAmerican |
4.86199969174095E-10 |
| Normal-vs-Asian |
1.996050E-01 |
| Caucasian-vs-AfricanAmerican |
3.016800E-01 |
| Caucasian-vs-Asian |
7.200000E-01 |
| AfricanAmerican-vs-Asian |
6.208200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.84865489372532E-12 |
| Normal-vs-Female |
1.43569999999649E-06 |
| Male-vs-Female |
2.264400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.42270000000633E-06 |
| Normal-vs-Extreme_Weight |
1.80577774955282E-12 |
| Normal-vs-Obese |
6.68570000028623E-07 |
| Normal-vs-Extreme_Obese |
1.036430E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.892200E-02 |
| Normal_Weight-vs-Obese |
7.229200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.904800E-01 |
| Extreme_Weight-vs-Obese |
1.287840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.196400E-01 |
| Obese-vs-Extreme_Obese |
8.798800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.204650E-01 |
| Normal-vs-Age(41-60Yrs) |
4.82439643789689E-11 |
| Normal-vs-Age(61-80Yrs) |
1.36260003280597E-10 |
| Normal-vs-Age(81-100Yrs) |
9.93150000017096E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.731560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.127620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.587700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.693200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.621010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.505400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66566760384512E-12 |
| Normal-VS-Type2 PRCC |
1.984930E-03 |
| Normal-VS-KIRP CIMP |
2.323400E-01 |
| Normal-VS-Unclassified PRCC |
9.56469999979781E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.964600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.375700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.737800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.008200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.304300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.579900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31229999977833E-07 |
| Normal-vs-N1 |
9.332200E-02 |
| Normal-vs-N2 |
2.385800E-01 |
| N0-vs-N1 |
3.234100E-02 |
| N0-vs-N2 |
7.983400E-01 |
| N1-vs-N2 |
4.803000E-01 |
|
|
